Log In
Print
BCIQ
Print
Print this Print this
 

Riboxxim

  Manage Alerts
Collapse Summary General Information
Company Riboxx GmbH
DescriptionToll-like receptor 3 (TLR3) agonist
Molecular Target Toll-like receptor 3 (TLR3)
Mechanism of ActionToll-like receptor 3 (TLR3) agonist
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard Indication Infectious (unspecified)
Indication DetailsTreat undisclosed infectious disease
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today